Aminocyclopentanone amides and pharmaceutical formulation
US4371530A · kind A · utility
7Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 1981 |
| Grant date | Feb 1, 1983 |
| Priority date | — |
| Expiry date | Jul 2, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds are described of the formula ##STR1## in which R.sup.1 is unsubstituted or substituted phenylalkyl, thienylalkyl or naphthylalkyl, or cinnamyl; PA0 R.sup.2 is a hydrogen atom, methyl or alkyl substituted by alkoxy or --COOH; PA0 W is alkylene; PA0 X is cis or trans --CH.dbd.CH-- or --CH.sub.2 CH.sub.2 --; and PA0 Y is a saturated heterocyclic amino group having 5-8 ring members; and their salts and solvates. These compounds inhibit blood platelet aggregation and bronchoconstriction and may be formulated for use as antithrombotic and anti-asthmatic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.